136 related articles for article (PubMed ID: 28801587)
1. Temozolomide arrests glioma growth and normalizes intratumoral extracellular pH.
Rao JU; Coman D; Walsh JJ; Ali MM; Huang Y; Hyder F
Sci Rep; 2017 Aug; 7(1):7865. PubMed ID: 28801587
[TBL] [Abstract][Full Text] [Related]
2. Imaging the intratumoral-peritumoral extracellular pH gradient of gliomas.
Coman D; Huang Y; Rao JU; De Feyter HM; Rothman DL; Juchem C; Hyder F
NMR Biomed; 2016 Mar; 29(3):309-19. PubMed ID: 26752688
[TBL] [Abstract][Full Text] [Related]
3. Towards longitudinal mapping of extracellular pH in gliomas.
Huang Y; Coman D; Herman P; Rao JU; Maritim S; Hyder F
NMR Biomed; 2016 Oct; 29(10):1364-72. PubMed ID: 27472471
[TBL] [Abstract][Full Text] [Related]
4. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.
Yu Z; Xie G; Zhou G; Cheng Y; Zhang G; Yao G; Chen Y; Li Y; Zhao G
Cancer Lett; 2015 Oct; 367(1):58-68. PubMed ID: 26188279
[TBL] [Abstract][Full Text] [Related]
5. Imaging temozolomide-induced changes in the myeloid glioma microenvironment.
Foray C; Valtorta S; Barca C; Winkeler A; Roll W; Müther M; Wagner S; Gardner ML; Hermann S; Schäfers M; Grauer OM; Moresco RM; Zinnhardt B; Jacobs AH
Theranostics; 2021; 11(5):2020-2033. PubMed ID: 33500706
[No Abstract] [Full Text] [Related]
6. Extracellular pH mapping of liver cancer on a clinical 3T MRI scanner.
Coman D; Peters DC; Walsh JJ; Savic LJ; Huber S; Sinusas AJ; Lin M; Chapiro J; Constable RT; Rothman DL; Duncan JS; Hyder F
Magn Reson Med; 2020 May; 83(5):1553-1564. PubMed ID: 31691371
[TBL] [Abstract][Full Text] [Related]
7. Mapping Extracellular pH of Gliomas in Presence of Superparamagnetic Nanoparticles: Towards Imaging the Distribution of Drug-Containing Nanoparticles and Their Curative Effect on the Tumor Microenvironment.
Maritim S; Coman D; Huang Y; Rao JU; Walsh JJ; Hyder F
Contrast Media Mol Imaging; 2017; 2017():3849373. PubMed ID: 29362558
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Cyclin D1 Expression in Human Glioblastoma Cells is Associated with Increased Temozolomide Chemosensitivity.
Zhang D; Dai D; Zhou M; Li Z; Wang C; Lu Y; Li Y; Wang J
Cell Physiol Biochem; 2018; 51(6):2496-2508. PubMed ID: 30562739
[TBL] [Abstract][Full Text] [Related]
9. CEST-MRI for glioma pH quantification in mouse model: Validation by immunohistochemistry.
Ferrauto G; Di Gregorio E; Auboiroux V; Petit M; Berger F; Aime S; Lahrech H
NMR Biomed; 2018 Nov; 31(11):e4005. PubMed ID: 30256478
[TBL] [Abstract][Full Text] [Related]
10. Regression of glioma tumor growth in F98 and U87 rat glioma models by the Nitrone OKN-007.
Towner RA; Gillespie DL; Schwager A; Saunders DG; Smith N; Njoku CE; Krysiak RS; Larabee C; Iqbal H; Floyd RA; Bourne DW; Abdullah O; Hsu EW; Jensen RL
Neuro Oncol; 2013 Mar; 15(3):330-40. PubMed ID: 23328810
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of DNA-repair genes Ercc1 and Mgmt enhances temozolomide efficacy in gliomas treatment: a pre-clinical study.
Boccard SG; Marand SV; Geraci S; Pycroft L; Berger FR; Pelletier LA
Oncotarget; 2015 Oct; 6(30):29456-68. PubMed ID: 26336131
[TBL] [Abstract][Full Text] [Related]
12. OKN-007 decreases tumor necrosis and tumor cell proliferation and increases apoptosis in a preclinical F98 rat glioma model.
de Souza PC; Balasubramanian K; Njoku C; Smith N; Gillespie DL; Schwager A; Abdullah O; Ritchey JW; Fung KM; Saunders D; Jensen RL; Towner RA
J Magn Reson Imaging; 2015 Dec; 42(6):1582-91. PubMed ID: 25920494
[TBL] [Abstract][Full Text] [Related]
13. Atorvastatin Promotes Cytotoxicity and Reduces Migration and Proliferation of Human A172 Glioma Cells.
Oliveira KA; Dal-Cim T; Lopes FG; Ludka FK; Nedel CB; Tasca CI
Mol Neurobiol; 2018 Feb; 55(2):1509-1523. PubMed ID: 28181188
[TBL] [Abstract][Full Text] [Related]
14. Acquisition of temozolomide resistance by the rat C6 glioma cell line increases cell migration and side population phenotype.
Xu Y; Yang X; Mei S; Sun Y; Li J
Oncol Rep; 2019 Dec; 42(6):2355-2362. PubMed ID: 31578583
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol enhances the therapeutic effect of temozolomide against malignant glioma in vitro and in vivo by inhibiting autophagy.
Lin CJ; Lee CC; Shih YL; Lin TY; Wang SH; Lin YF; Shih CM
Free Radic Biol Med; 2012 Jan; 52(2):377-91. PubMed ID: 22094224
[TBL] [Abstract][Full Text] [Related]
16. KLF8 Promotes Temozolomide Resistance in Glioma Cells via β-Catenin Activation.
Yu G; Wu F; Wang E
Cell Physiol Biochem; 2016; 38(4):1596-604. PubMed ID: 27081861
[TBL] [Abstract][Full Text] [Related]
17. Transmembrane pH gradient imaging in rodent glioma models.
Mishra SK; Santana JG; Mihailovic J; Hyder F; Coman D
NMR Biomed; 2024 May; 37(5):e5102. PubMed ID: 38263680
[TBL] [Abstract][Full Text] [Related]
18. Noninvasive diffusion magnetic resonance imaging of brain tumour cell size for the early detection of therapeutic response.
Roberts TA; Hyare H; Agliardi G; Hipwell B; d'Esposito A; Ianus A; Breen-Norris JO; Ramasawmy R; Taylor V; Atkinson D; Punwani S; Lythgoe MF; Siow B; Brandner S; Rees J; Panagiotaki E; Alexander DC; Walker-Samuel S
Sci Rep; 2020 Jun; 10(1):9223. PubMed ID: 32514049
[TBL] [Abstract][Full Text] [Related]
19. Systemic anti-hepatocyte growth factor monoclonal antibody therapy induces the regression of intracranial glioma xenografts.
Kim KJ; Wang L; Su YC; Gillespie GY; Salhotra A; Lal B; Laterra J
Clin Cancer Res; 2006 Feb; 12(4):1292-8. PubMed ID: 16489086
[TBL] [Abstract][Full Text] [Related]
20. The Glycoside Oleandrin Reduces Glioma Growth with Direct and Indirect Effects on Tumor Cells.
Garofalo S; Grimaldi A; Chece G; Porzia A; Morrone S; Mainiero F; D'Alessandro G; Esposito V; Cortese B; Di Angelantonio S; Trettel F; Limatola C
J Neurosci; 2017 Apr; 37(14):3926-3939. PubMed ID: 28292827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
